CCOYX
Price
$125.26
Change
+$4.43 (+3.67%)
Updated
Apr 24 closing price
Net Assets
11.36B
MTCCX
Price
$37.64
Change
+$1.10 (+3.01%)
Updated
Apr 24 closing price
Net Assets
1.73B
Ad is loading...

CCOYX vs MTCCX

Header iconCCOYX vs MTCCX Comparison
Open Charts CCOYX vs MTCCXBanner chart's image
Columbia Seligman Tech & Info Inst3
Price$125.26
Change+$4.43 (+3.67%)
VolumeN/A
Net Assets11.36B
MFS Technology C
Price$37.64
Change+$1.10 (+3.01%)
VolumeN/A
Net Assets1.73B
CCOYX vs MTCCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CCOYX vs. MTCCX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCOYX is a Buy and MTCCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CCOYX has more cash in the bank: 11.4B vs. MTCCX (1.73B). CCOYX (0.00) and MTCCX (0.00) have matching dividends . CCOYX was incepted earlier than MTCCX: CCOYX (8 years) vs MTCCX (25 years). MTCCX (1.89) is less costly to investors than CCOYX (0.85). CCOYX is a more actively managed with annual turnover of: 39.00 vs. MTCCX (37.00). MTCCX has a lower initial minimum investment than CCOYX: MTCCX (1000) vs CCOYX (1000000). CCOYX annual gain was more profitable for investors over the last year : -10.26 vs. MTCCX (-15.00). CCOYX return over 5 years is better than : 53.43 vs. MTCCX (-7.68).
CCOYXMTCCXCCOYX / MTCCX
Total Expense Ratio0.851.8845%
Annual Report Gross Expense Ratio0.851.8945%
Fund Existence8 years25 years-
Gain YTD-18.181-15.534117%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets11.4B1.73B660%
Annual Yield % from dividends0.000.00-
Returns for 1 year-10.26-15.0068%
Returns for 3 years-0.57-12.525%
Returns for 5 years53.43-7.68-696%
Returns for 10 yearsN/A59.08-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AQST2.850.03
+1.06%
Aquestive Therapeutics
GSBD10.760.09
+0.84%
Goldman Sachs BDC
LMT466.813.26
+0.70%
Lockheed Martin Corp
IKNA1.21N/A
N/A
Ikena Oncology
HRB58.81-0.56
-0.94%
H&R Block